257. 肝型糖原病 Hepatic glycogenosis Clinical trials / Disease details

臨床試験数 : 14 / 薬物数 : 27 - (DrugBank : 7) / 標的遺伝子数 : 3 - 標的パスウェイ数 : 8

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04930627 (ClinicalTrials.gov)	July 2021	11/6/2021	Safety and Efficacy of Empagliflozin in GSD1b Patients With Neutropenia	Evaluation of Efficacy and Safety of Empagliflozin in Treatment of Neutropenia in Patients With Glycogenosis Ib	Glucose 6 Phosphatase Deficiency	Drug: Empagliflozin	Children's Memorial Health Institute, Poland	Department of Internal Medicine, Hypertension and Vascular Diseases, The Medical University of Warsaw	Not yet recruiting	N/A	N/A	All	20	Phase 2	Poland
2	NCT03218904 (ClinicalTrials.gov)	March 17, 2017	13/7/2017	Glycogen Storage Disease Breath Test Study	Application of Novel Techniques to Devise Nutritional Therapies in Subjects With Glycogen Storage Disease Type I	Patient Compliance;Healthy	Dietary Supplement: Glucose intake;Dietary Supplement: Carbohydrates intake	University of British Columbia	Saudi Arabian Cultural Bureau, Ottawa;Canadian Institutes of Health Research (CIHR)	Recruiting	5 Years	35 Years	All	38	N/A	Canada
3	NCT02176096 (ClinicalTrials.gov)	July 2014	24/6/2014	Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial	Comparison of the Effect of a Novel Starch (Glycosade) Versus Gastrostomy Tube-Dextrose Infusion on Overnight Euglycaemia Control in Children With Glycogen Storage Disease Type I: Open Label Demonstration Trial	Glycogen Storage Disorder Type 1;Hypoglycemia;Cornstarch;Glycosade	Dietary Supplement: Glycosade	University of Manitoba	Co-Investigator - Dr. Cheryl Rockman-Greenberg	Completed	5 Years	18 Years	All	4	N/A	Canada